Market volatility was back this week, and IPOs either dropped out or dropped their valuations. Six companies in five different sectors raised a combined $992 million, along with one SPAC. Four of the six deals priced below the midpoint of the range, and five...read more
Evolus, which is preparing to launch a biosimilar version of Botox, raised $60 million by offering 5 million shares at $12, the low end of the range of $12 to $14. Evolus plans to list on the Nasdaq under the symbol EOLS. Cantor Fitzgerald and Mizuho...read more
January's record-breaking activity is spilling over into February. Ten companies are targeting a combined $1.8 billion. Headlined by three energy companies, deals include an Argentine ag-tech, a Turkish Burger King franchisee, a Chinese wearables manufacturer,...read more
What 2018’s IPOs Tell Us About 2H18
...read more
US IPO Weekly Recap: Volatility shakes IPO market as 6 deals price and most break issue
Market volatility was back this week, and IPOs either dropped out or dropped their valuations. Six companies in five different sectors raised a combined $992 million, along with one SPAC. Four of the six deals priced below the midpoint of the range, and five...read more
Evolus prices IPO at $12, the low end of the range
Evolus, which is preparing to launch a biosimilar version of Botox, raised $60 million by offering 5 million shares at $12, the low end of the range of $12 to $14. Evolus plans to list on the Nasdaq under the symbol EOLS. Cantor Fitzgerald and Mizuho...read more
US IPO Week Ahead: 10 deals expected with energy leading the way
January's record-breaking activity is spilling over into February. Ten companies are targeting a combined $1.8 billion. Headlined by three energy companies, deals include an Argentine ag-tech, a Turkish Burger King franchisee, a Chinese wearables manufacturer,...read more